Optical Imaging Scans for the Diagnosis of Skin Cancer in Patients With Lesions

Part of paid clinical trials in Atlanta, Georgia.

Sponsor
Emory University
Study ID
NCT07213154
Status
Recruiting
Apply to this trial

Conditions

  • Malignant Skin Neoplasm
  • Skin Disorder
  • Skin Neoplasm

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Quantitative Oblique Back-Illumination Microscopy — PROCEDURE
    Undergo qOBM
  • Radiation Therapy — RADIATION
    Undergo SOC RT

Study Details

This clinical trial studies how well an optical imaging scan called quantitative oblique back-illumination microscopy (qOBM) helps in diagnosing skin cancer in patients with skin lesions. qOBM is a non-invasive procedure that uses red light for illumination, and may work better than no imaging procedures in aiding doctors in diagnosing skin lesions.

Key Dates

Start date
Oct 15, 2025
Status verified
Dec 2025
Primary completion
Sep 17, 2026
Completion
Sep 17, 2027

Study Design

Enrollment
10 participants (estimated)
Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC

Arms

  • Experimental: Group I (qOBM)
    Patients who have skin melanoma and/or suspected dysplastic nevi undergo qOBM optical imaging scan on study. Patients may undergo 2 additional qOBM optical imaging scans at the discretion of the treating physician. After qOBM scans, patients who are diagnosed with skin cancer may proceed to Group II.
  • Experimental: Group II (qOBM, SOC RT)
    GROUP II: Patients with skin cancer who are undergoing SOC RT undergo qOBM optical imaging scans prior to- and during or after SOC RT on study. Patients may also undergo qOBM optical imaging scans additional at approximately 1, 6, and 12 months after completion of SOC RT at the discretion of the treating physician.

Primary Outcome Measure

qOBM Clinical Assessment [ Time Frame: Up to 12 months ]

Central Contacts

Locations (2)

FacilityCityStateZIPSite coordinators
Emory University Hospital MidtownAtlantaGeorgia30308
Tiffaney Roundtree
[email protected]
Mohammad K. Khan, MD, PhD, MS, FACRO, FACR, DABR (PRINCIPAL_INVESTIGATOR)
Emory University Hospital/Winship Cancer InstituteAtlantaGeorgia30322
Tiffaney K. Roundtree
[email protected]
Mohammad K. Khan, MD, PhD, MS, FACRO, FACR, DABR (PRINCIPAL_INVESTIGATOR)

Find similar trials in Atlanta, GA

By research site
Emory University Hospital Midtown· Atlanta, GAEmory University Hospital/Winship Cancer Institute· Atlanta, GA

Related Studies